Listed by the USPTO as PIHONAK, SARAH
Tech Center 1600 • Art Units: 1617 1627
This examiner grants 61% of resolved cases
PIHONAK, SARAH works in Tech Center 1600 and Art Unit 1617. The profile covers 1522 resolved cases, with a 61.4% allowance rate, a 42.3% interview lift, and a 1027-day median time to allowance. The large record provides a substantial basis for planning, and the interview result identifies direct examiner engagement as a meaningful prosecution tool.
The leading companies are ThermoLife International LLC, Nevakar Injectables Inc., and The University of British Columbia. The leading firms are BOOTH UDALL, PLC, Adler Pollock & Sheehan P.C., and ARENTFOX SCHIFF LLP. Practitioners should use interviews to focus the dispute, then document agreed or unresolved points in a targeted written response.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18579786 | COMPOSITIONS COMPRISING CONSTITUENTS, DERIVATIVES OR EXTRACTS OF CANNABIS | Final Rejection | Nicoventures Trading Limited |
| 19556549 | AMINO ACID COMPOSITIONS | Non-Final OA | ThermoLife International, LLC |
| 19556505 | AMINO ACID COMPOSITIONS | Non-Final OA | ThermoLife International, LLC |
| 19556587 | AMINO ACID COMPOSITIONS | Non-Final OA | ThermoLife International, LLC |
| 18035578 | A Method of Treating Depression by Immune Modulation | Non-Final OA | The University of British Columbia |
| 17691745 | HETEROAROMATIC ELECTROPHILES AND METHODS OF USING THEREOF | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 18040515 | METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME | Final Rejection | Temple University-Of The Commonwealth System of Higher Education |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.4% of resolved applications examined by Sarah Pihonak were allowed (1,522 resolved cases), compared with 34.2% across Art Unit 1617 over the last five years.
This examiner's interview lift is +42.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sarah Pihonak took 1,027 days on average from filing to allowance.
Sarah Pihonak examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).